Moyamoya Disease and the Risk of Parkinson's Disease
ABSTRACT Objectives Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by the progressive narrowing of arteries at the base of the brain, forming abnormal collateral vascular networks. While vascular parkinsonism is noted in MMD, its link to Parkinson's disease (PD) has not been explored.
Dallah Yoo +9 more
wiley +1 more source
Targeting rare splicing defects: Antisense oligonucleotides offer a therapeutic strategy in FRDA. [PDF]
Kerkhof LMC, Buijsen RAM.
europepmc +1 more source
ABSTRACT Objective The optimal treatment for neurosarcoidosis myelitis is uncertain. We characterize incident neurosarcoidosis myelitis and assess treatment response by MRI and clinical scales. Methods Incident probable or definite neurosarcoidosis myelitis in adults was retrospectively identified from 13 academic medical centers.
Giovanna S. Manzano +39 more
wiley +1 more source
Enhancing Anticancer Effects: Targeted Doxorubicin Delivery Using UiO-66-NH<sub>2</sub>-FA Metal-Organic Framework Combined with Autophagy Inhibition by Hydroxychloroquine in Colorectal Cancer Cells. [PDF]
Saffar A +6 more
europepmc +1 more source
Addressing the hypothyroidism impasse - seeking a consensus for the treatment of dissatisfied hypothyroid patients. [PDF]
Welborn T.
europepmc +1 more source
Linezolid and Meropenem for Nocardia otitidiscaviarum Actinomycetoma, India. [PDF]
Sardana K +5 more
europepmc +1 more source
Olutasidenib alone or combined with azacitidine in patients with mutant IDH1 myelodysplastic syndrome. [PDF]
Cortes JE +10 more
europepmc +1 more source
Antimicrobial effect of benzbromarone combined with colistin against multidrug-resistant bacteria. [PDF]
Wang F, Li H, Bao X.
europepmc +1 more source
Modeling Influenza Antiviral Strategies: Reducing Burden and Preventing Resistance. [PDF]
Pasco R, Hayden FG, Meyers LA.
europepmc +1 more source

